81 – 90 of 491
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Bortezomib-induced peripheral neuropathy : A genome-wide association study on multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Levels of DNA damage (Micronuclei) in patients suffering from chronic kidney disease. Role of GST polymorphisms
(
- Contribution to journal › Article
-
Mark
Second primary cancers in non-Hodgkin lymphoma : Bidirectional analyses suggesting role for immune dysfunction
(
- Contribution to journal › Article
-
Mark
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer : a nationwide, observational follow up study in Sweden
(
- Contribution to journal › Article
-
Mark
Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
(
- Contribution to journal › Article
-
Mark
Chemotherapy-induced peripheral neuropathy : Evidence from genome-wide association studies and replication within multiple myeloma patients
(
- Contribution to journal › Article
-
Mark
Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma
(
- Contribution to journal › Letter
-
Mark
Genetic variation of acquired structural chromosomal aberrations
(
- Contribution to journal › Article
-
Mark
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
(
- Contribution to journal › Article
-
Mark
Response : Methods for second primary cancers evaluation have to be standardized (IJC-17-2354)
(
- Contribution to journal › Debate/Note/Editorial